These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 35416588)

  • 1. Mortality in People with Type 2 Diabetes Following SARS-CoV-2 Infection: A Population Level Analysis of Potential Risk Factors.
    Heald AH; Jenkins DA; Williams R; Sperrin M; Mudaliar RN; Syed A; Naseem A; Bowden Davies KA; Peng Y; Peek N; Ollier W; Anderson SG; Delanerolle G; Gibson JM
    Diabetes Ther; 2022 May; 13(5):1037-1051. PubMed ID: 35416588
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Risk Factors Potentially Influencing Hospital Admission in People with Diabetes, Following SARS-CoV-2 Infection: A Population-Level Analysis.
    Heald AH; Jenkins DA; Williams R; Sperrin M; Fachim H; Mudaliar RN; Syed A; Naseem A; Gibson JM; Bowden Davies KA; Peek N; Anderson SG; Peng Y; Ollier W
    Diabetes Ther; 2022 May; 13(5):1007-1021. PubMed ID: 35325361
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sars-Cov-2 Infection in People with Type 1 Diabetes and Hospital Admission: An Analysis of Risk Factors for England.
    Heald AH; Jenkins DA; Williams R; Mudaliar RN; Khan A; Syed A; Sattar N; Khunti K; Naseem A; Bowden-Davies KA; Gibson JM; Ollier W;
    Diabetes Ther; 2023 Dec; 14(12):2031-2042. PubMed ID: 37620452
    [TBL] [Abstract][Full Text] [Related]  

  • 4. COVID-19 Vaccination and Diabetes Mellitus: How Much Has It Made a Difference to Outcomes Following Confirmed COVID-19 Infection?
    Heald AH; Jenkins DA; Williams R; Mudaliar RN; Naseem A; Davies KAB; Gibson JM; Peng Y; Ollier W
    Diabetes Ther; 2023 Jan; 14(1):193-204. PubMed ID: 36478309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence of long COVID in people with diabetes mellitus-evidence from a UK cohort.
    Heald AH; Williams R; Jenkins DA; Stewart S; Bakerly ND; Mccay K; Ollier W
    EClinicalMedicine; 2024 May; 71():102607. PubMed ID: 38813442
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Admission eGFR predicts in-hospital mortality independently of admission glycemia and C-peptide in patients with type 2 diabetes mellitus and COVID-19.
    Infante M; Pieri M; Lupisella S; Mohamad A; Bernardini S; Della-Morte D; Fabbri A; De Stefano A; Iannetta M; Ansaldo L; Crea A; Andreoni M; Morello M
    Curr Med Res Opin; 2023 Apr; 39(4):505-516. PubMed ID: 36749566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors for COVID-19 case fatality rate in people with type 1 and type 2 diabetes mellitus: A nationwide retrospective cohort study of 235,248 patients in the Russian Federation.
    Shestakova MV; Vikulova OK; Elfimova AR; Deviatkin AA; Dedov II; Mokrysheva NG
    Front Endocrinol (Lausanne); 2022; 13():909874. PubMed ID: 36017317
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dipeptidyl-peptidase (DPP)-4 inhibitors and glucagon-like peptide (GLP)-1 analogues for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk for the development of type 2 diabetes mellitus.
    Hemmingsen B; Sonne DP; Metzendorf MI; Richter B
    Cochrane Database Syst Rev; 2017 May; 5(5):CD012204. PubMed ID: 28489279
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combining glucagon-like peptide-1 receptor agonists (GLP-1RAs) and sodium-glucose cotransporter-2 inhibitors (SGLT2is) in patients with type 2 diabetes mellitus (T2DM).
    Gourdy P; Darmon P; Dievart F; Halimi JM; Guerci B
    Cardiovasc Diabetol; 2023 Apr; 22(1):79. PubMed ID: 37005640
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lower COVID-19 Mortality in Patients with Type 2 Diabetes Mellitus Taking Dipeptidyl Peptidase-4 Inhibitors: Results from a Turkish Nationwide Study.
    Emral R; Haymana C; Demirci I; Tasci I; Sahin M; Cakal E; Ata N; Unluturk U; Demir T; Ertugrul D; Sahin I; Atmaca A; Celik O; Caglayan M; Arga KY; Dagdelen S; Salman S; Satman I; Sonmez A
    Diabetes Ther; 2021 Nov; 12(11):2857-2870. PubMed ID: 34398433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. All-cause mortality and cardiovascular outcomes with sodium-glucose Co-transporter 2 inhibitors, glucagon-like peptide-1 receptor agonists and with combination therapy in people with type 2 diabetes.
    Riley DR; Essa H; Austin P; Preston F; Kargbo I; Ibarburu GH; Ghuman R; Cuthbertson DJ; Lip GYH; Alam U
    Diabetes Obes Metab; 2023 Oct; 25(10):2897-2909. PubMed ID: 37385958
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association between use of novel glucose-lowering drugs and COVID-19 hospitalization and death in patients with type 2 diabetes: a nationwide registry analysis.
    Ferrannini G; Lund LH; Benson L; Rizzo M; Almahmeed W; Rosano GMC; Savarese G; Cosentino F
    Eur Heart J Cardiovasc Pharmacother; 2022 Dec; 9(1):10-17. PubMed ID: 35963647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The renoprotective effects of sodium-glucose cotransporter 2 inhibitors versus placebo in patients with type 2 diabetes with or without prevalent kidney disease: A systematic review and meta-analysis.
    Wang C; Zhou Y; Kong Z; Wang X; Lv W; Geng Z; Wang Y
    Diabetes Obes Metab; 2019 Apr; 21(4):1018-1026. PubMed ID: 30565382
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alpha-glucosidase inhibitors for prevention or delay of type 2 diabetes mellitus and its associated complications in people at increased risk of developing type 2 diabetes mellitus.
    Moelands SV; Lucassen PL; Akkermans RP; De Grauw WJ; Van de Laar FA
    Cochrane Database Syst Rev; 2018 Dec; 12(12):CD005061. PubMed ID: 30592787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glucagon-Like Peptide-1 Receptor Agonist Use in People Living with Type 2 Diabetes Mellitus and Chronic Kidney Disease: A Narrative Review of the Key Evidence with Practical Considerations.
    Górriz JL; Romera I; Cobo A; O'Brien PD; Merino-Torres JF
    Diabetes Ther; 2022 Mar; 13(3):389-421. PubMed ID: 35175551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type 2 diabetes: A protective factor for COPD?
    Rayner LH; McGovern AP; Sherlock J; Gatenby P; Correa A; Creagh-Brown B; de Lusignan S
    Prim Care Diabetes; 2018 Oct; 12(5):438-444. PubMed ID: 29843977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reconvalescent plasma/camostat mesylate in early SARS-CoV-2 Q-PCR positive high-risk individuals (RES-Q-HR): a structured summary of a study protocol for a randomized controlled trial.
    Keitel V; Jensen B; Feldt T; Fischer JC; Bode JG; Matuschek C; Bölke E; Budach W; Plettenberg C; Scheckenbach K; Kindgen-Milles D; Timm J; Müller L; Kolbe H; Stöhr A; Calles C; Hippe A; Verde P; Spinner CD; Schneider J; Wolf T; Kern WV; Nattermann J; Zoufaly A; Ohmann C; Luedde T;
    Trials; 2021 May; 22(1):343. PubMed ID: 34001215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19.
    Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association Between Glucagon-Like Peptide 1 Receptor Agonist and Sodium-Glucose Cotransporter 2 Inhibitor Use and COVID-19 Outcomes.
    Kahkoska AR; Abrahamsen TJ; Alexander GC; Bennett TD; Chute CG; Haendel MA; Klein KR; Mehta H; Miller JD; Moffitt RA; Stürmer T; Kvist K; Buse JB;
    Diabetes Care; 2021 Jul; 44(7):1564-1572. PubMed ID: 34135013
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.